Dominique Kinnett-Hopkins

Dominique Kinnett-Hopkins

Auto-generated profile, based on publicly available information

Dominique Kinnett-Hopkins

University of Michigan

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
DKD. Kinnett-Hopkins
D. Kinnett-Hopkins
BAB. Adamson
B. Adamson
KRKathryn Rougeau
Kathryn Rougeau
Robert MotlRobert Motl
Robert Motl

1 March 2017 in Contemporary Clinical Trials
Verified
Journal Article
Closed access
YLYvonne C Learmonth
Yvonne C Learmonth
BABrynn Adamon
Brynn Adamon
DKDominique Kinnett-Hopkins
Dominique Kinnett-Hopkins
MBMaria Bohri
Maria Bohri
Robert MotlRobert Motl
Robert Motl

1 January 2016 in Multiple Sclerosis Journal – Experimental, Translational and Clinical
Verified
Journal Article
Open access
JBJulia M Balto
Julia M Balto
DKDominique L Kinnett-Hopkins
Dominique L Kinnett-Hopkins
Robert MotlRobert Motl
Robert Motl
Background: There is increased interest in the application of smartphone applications and wearable motion sensors among multiple sclerosis (MS) patients. Objective: This study examined the accuracy and precision of common smartphone applications and motion sensors for measuring steps taken by MS patients while walking on a treadmill. Methods: Forty-five MS patients (Expanded Disability Status Scale (EDSS) = 1.0–5.0) underwent two 500-step walking trials at comfortable walking speed on a treadmill. Participants wore five motion sensors: the Digi-Walker SW-200 pedometer (Yamax), the UP2 and UP Move (Jawbone), and the Flex and One (Fitbit). The smartphone applications were Health (Apple), Health Mate (Withings), and Moves (ProtoGeo Oy). Results: The Fitbit One had the best absolute (mean = 490.6 steps, 95% confidence interval (CI) = 485.6–495.5 steps) and relative accuracy (1.9% error), and absolute (SD = 16.4) and relative precision (coefficient of variation (CV) = 0.0), for the first 500-step walking trial; this was repeated with the second trial. Relative accuracy was correlated with slower walking speed for the first ( rs = −.53) and second ( rs = −.53) trials. Conclusion: The results suggest that the waist-worn Fitbit One is the most precise and accurate sensor for measuring steps when walking on a treadmill, but future research is needed (testing the device across a broader range of disability, at different speeds, and in real-life walking conditions) before inclusion in clinical research and practice with MS patients.

1 March 2016 in Contemporary Clinical Trials
Verified
Journal Article
Closed access
BABrynn Adamon
Brynn Adamon
YLYvonne C Learmonth
Yvonne C Learmonth
DKDominique Kinnett-Hopkins
Dominique Kinnett-Hopkins
MBMaria Bohri
Maria Bohri
Robert MotlRobert Motl
Robert Motl

3 December 2015 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
Robert MotlRobert Motl
Robert Motl
YLYvonne C Learmonth
Yvonne C Learmonth
TWThomas R. Wójcicki
Thomas R. Wójcicki
JFJason Fanning
Jason Fanning
EHElizabeth A. Hubbard
Elizabeth A. Hubbard
EMEdward McAuley
Edward McAuley
There are relatively few standard, objective measures for studying physical function among older adults with multiple sclerosis (MS), yet such measures are necessary considering the shift in prevalence and associated consequences of both MS and older age on physical function. We undertook a preliminary examination of the construct validity of Short Physical Performance Battery (SPPB) scores in older adults with MS based on an expected differential pattern of associations with measures of lower and upper extremity function. The sample included 48 persons with MS aged 50 years and older who were enrolled in a pilot, randomized controlled trial of exercise training. Participants completed the SPPB and other objective and self-report measures of lower and upper extremity function as part of baseline testing. SPPB scores demonstrated strong associations with measures of lower extremity function (|r s| = .66–.79), and weak associations with measures of upper extremity function (|r s| = .03–.33). We provide preliminary evidence that supports the validity of scores from the SPPB as a measure of lower extremity function for inclusion in clinical research and practice involving older adults with MS.

1 January 2016 in Aging and disease
Verified
Journal Article
Open access
PDF file
RKRachel E. Klaren
Rachel E. Klaren
ESEmerson Sebastiao
Emerson Sebastiao
CCChung-Yi Chiu
Chung-Yi Chiu
DKDominique Kinnett-Hopkins
Dominique Kinnett-Hopkins
EMEdward McAuley
Edward McAuley
Robert MotlRobert Motl
Robert Motl
There is much evidence supporting the safety and benefits of physical activity in adults with multiple sclerosis (MS) and recent evidence of beneficial effects on physical function in older adults with MS. However, there is very little known about physical activity participation in older adults with conditions such as MS. This study compared levels of physical activity (i.e., sedentary behavior, light physical activity (LPA), and moderate-to-vigorous physical activity (MVPA)) and rates of meeting public health guidelines for MVPA (i.e., ≥30 min/day) among young (i.e., ages 20-39 years), middle-aged (i.e., ages 40-59 years) and older adults (i.e., ages ≥60 years) with MS. The sample included 963 persons with MS who provided demographic and clinical information and wore an accelerometer for a 7-day period. The primary analysis involved a between-subjects ANOVA on accelerometer variables (i.e., accelerometer wear time; number of valid days; sedentary behavior in min/day; LPA in min/day; and MVPA in min/day). Collectively, our data indicated that older adults with MS engaged in less MVPA and more sedentary behavior than middle-aged and young adults with MS. Such results highlight the importance of developing physical activity interventions as an effective means for managing the progression and consequences of MS in older adults.